- £374.86m
- £329.06m
- £1.95bn
Annual income statement for Impellam, fiscal year end - January 3rd, GBP millions except per share, conversion factor applied.
2021 January 1st | R2021 December 31st | 2022 December 30th | 2024 January 5th | 2025 January 3rd | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 53 W | 52 W |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,001 | 1,580 | 1,947 | 2,076 | 1,851 |
| Cost of Revenue | |||||
| Gross Profit | 228 | 161 | 205 | 200 | — |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,016 | 1,567 | 1,926 | 2,059 | — |
| Operating Profit | -15 | 13.7 | 21 | 17.2 | — |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -20.4 | 9.8 | 16.1 | 13.5 | -21.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -21.4 | 3.3 | 14.7 | 7.7 | — |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -21.4 | 8.2 | 25 | -2.5 | — |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -21.4 | 8.2 | 25 | -2.5 | — |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.05 | 0.073 | 0.356 | 0.19 | — |
| Dividends per Share | |||||
| Special Dividends per Share |